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[Abstract] This protocol describes the application of the CRISPR-Trap from designing of the gene 
targeting strategy to validation of successfully edited clones that was validated on various human cell 
lines, among them human induced pluripotent stem cells (hiPSCs). The advantage of CRISPR-Trap 
over conventional approaches is the complete removal of any endogenous full-length transcript from the 
target gene. CRISPR-Trap is applicable for any target gene with no or little coding sequence in its first 
exon. Several human cell lines and different genes have so far been edited successfully with CRISPR-
Trap. 
Keywords: CRISPR, CRISPR-Trap, Gene knockout, Gene replacement, Gene editing, hiPSCs 
 
[Background] The advent of CRISPR/Cas9 technology facilitated the genomic targeting for the 
generation of gene knockouts and gene editing. The conventional method to perform a knockout relies 
on the introduction of a frameshift leading to premature termination codons (PTCs), truncating the open 
reading frame (ORF) and subsequent degradation of the transcript of the targeted gene by nonsense-
mediated mRNA decay (NMD). A possible pitfall of this approach is full-length transcripts which may 
escape NMD and give rise to C-terminal truncated proteins harboring residual or even dominant 
negative functions. This protocol presents the CRISPR-Trap, a method we recently established (Reber 
et al., 2018), which upon successful editing will prevent the expression of any full-length transcript from 
the target gene locus (Figure 1). Simply put, this approach targets the first intron of the gene of interest 
with CRISPR/Cas9. Using homology-directed repair (HDR) a customizable cassette flanked by a strong 
3’-splice site and a strong polyadenylation signal is introduced in the first intron, thereby generating an 
artificial second and effectively last exon. Since transcription is terminated by the introduced 
polyadenylation signal, only the first endogenous exon and the inserted cassette is transcribed. The 
customizable cassette can be used to introduce a selection marker, thereby enabling easy selection for 
at least heterozygous edited clones. If a gene replacement is wanted, the customizable cassette can be 
used to introduce the replacement gene, followed by an internal ribosomal entry site (IRES) and a 
selection marker (Reber et al., 2016 and 2018). 
 
                 
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.  2 
www.bio-protocol.org/e3052     
Vol 8, Iss 20, Oct 20, 2018 
DOI:10.21769/BioProtoc.3052 
 
 
Figure 1. Schematic of the application of the CRISPR-Trap. The first intron of the target gene is 
cleaved using the CRISPR/Cas9 system and template DNA for homology-directed repair is provided. 
The template DNA contains a strong 3’ prime splice signal (dark green), a customizable cassette 
(light green) and a strong polyadenylation signal (turquoise). The customizable cassette can be 
utilized to either knockout (left) or replace the target gene (right). The cassette contains a selection 
marker that will be under the control of the endogenous promoter of the target gene upon successful 
editing. For gene replacements, an IRES is introduced in between the replacement gene and the 
selection marker. Figure adapted from Reber et al. (2018). 
 
Materials and Reagents 
 
1. Pipette tips 
a. 10 µl sapphire bulk non-sterile pipette tips (Greiner Bio One International, catalog number: 
771250) 
b. 200 µl polypropylene universal pipette tips with graduation (Greiner Bio One International, 
catalog number: 739282) 
c. 1,250 µl sapphire bulk non-sterile pipette tips (Greiner Bio One International, catalog 
number: 750250) 
2. TPP® tissue culture plates 
a. 24-well (Sigma-Aldrich, catalog number: Z707791) 
b. 6-well (Sigma-Aldrich, catalog number: Z707767) 
c. 15 cm plate (Sigma-Aldrich, catalog number: Z707694) 
3. TPP cell scraper 20 cm (MIDSCI, catalog number: TP99010) 
4. Cloning cylinder sterile, 3/16’’ ID x 5/16’’ H (SP Scienceware - Bel-Art Products - H-B Instrument, 
catalog number: 37847-0100) 
5. Cell strainer (EASYstrainer, 70 µm) (Greiner Bio One International, catalog number: 542070) 
6. Bel-ArtTM SP SciencewareTM BelpenTM black markers (SP Scienceware - Bel-Art Products - H-
B Instrument, catalog number: F13374-0000) 
7. Plasmid of choice, serving as homology directed repair donor template (donor plasmid) 
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8. Plasmid of choice for Cas9 and sgRNA expression, e.g., pX330-U6-Chimeric_BB-CBh-
hSpCas9 (Addgene, catalog number: 42230) 
9. Transformation competent E. coli strain of choice for cloning and plasmid amplification (e.g., 
XL10 Gold) (Agilent, catalog number: 200314) 
10. Transfection reagent of choice 
a. DogTor (OZ Biosciences, catalog number: DT51000) 
b. TransIT®-LT1 (Mirus Bio, catalog number: MIR 2300) 
c. LipofectamineTM 3000 reagent (Thermo Fisher Scientific, catalog number: L3000015) 
11. Cell detachment solutions 
a. hiPSCs 
i. To generate single cells: StemProTM AccutaseTM Cell Dissociation Reagent (Thermo 
Fisher Scientific, catalog number: A1110501) 
ii. To split cells as clumps: DPBS (STEMCELL Technologies, catalog number: 37350) 
containing 0.5 mM EDTA (Thermo Fisher Scientific, catalog number: 15575020) 
b. Other human cell lines: Trypsin-EDTA (0.05%), phenol red (Thermo Fisher Scientific, 
catalog number: 25300054) 
12. To grow hiPSCs as single cells: Y-27632, RHO/ROCK pathway inhibitor (STEMCELL 
Technologies, catalog number: 72302) 
13. ZeocinTM (InvivoGen, catalog number: ant-zn) 
14. Puromycin dihydrochloride (Santa Cruz Biotechnology, catalog number: sc-108071A) 
15. PBS (Ca2+, Mg2+ free) (Thermo Fisher Scientific, GibcoTM, catalog number: 10010023) 
16. TRIZOL (Sigma-Aldrich, catalog number: T9424) 
17. Dow Corning® High-Vacuum silicone Grease (Sigma-Aldrich, catalog number: Z273554) 
18. TOPOTM TA CloningTM Kit, Dual Promoter (Thermo Fisher Scientific, catalog number: 450640) 
19. Chloroform for analysis EMSURE® ACS, ISO, Reag. Ph Eur (Merck, catalog number: 102445) 
20. Absolute EtOH (Sigma-Aldrich, catalog number: 59176) 
21. Trisodium citrate (Sigma-Aldrich, catalog number: W302600) 
22. 2-propanol for analysis EMSURE® ACS, ISO, Reag. Ph Eur (Merck, catalog number: 109634) 
23. RNase free glycogen (Thermo Fisher Scientific, catalog number: R0551) 
24. DNA extraction kit (Quick-DNATM miniprep Kit) (ZYMO RESEARCH, catalog number: D3025) 
25. NaOH (Sigma-Aldrich, catalog number: 306576) 
26. Maximo Taq DNA Polymerase 2X-preMix/PCR Master Mix (GeneON, catalog number: S113) 
27. KAPA Taq ReadyMix PCR Kit (KAPA Biosystems, catalog number: KK1006) 
 
Equipment 
 
1. Pipettes  
a. Pipetman P10 (Gilson, catalog number: F144802) 
b. Pipetman P20 (Gilson, catalog number: F123600) 
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c. Pipetman P200 (Gilson, catalog number: F123601) 
d. Pipetman P1000 (Gilson, catalog number: F123602) 
2. Mammalian culture equipment 
3. Heat block (VWR, catalog number: 444-0938) 
4. Thermocycler (VWR, catalog number: 732-2551) 
5. NanoDrop (Thermo Fisher Scientific, model: NanoDropTM 2000, catalog number: ND-2000) 
6. Cooling Centrifuge (Eppendorf, model: 5424 R, catalog number: 5404000010) 
7. Wide-field microscope 
8. Vortex (Scientific Industries, catalog number: SI-0266) 
 
Software 
 
1. Clone manager (http://www.scied.com/pr_cmpro.htm) or other cloning software 
 
Procedure 
 
Notes:  
a. One has to be aware that the first exon of the target gene will still be expressed following the 
CRISPR-Trap strategy. Therefore, the ideal target gene has no or only few amino acids coded 
in its first exon. 
b. To allow direct selection for genome edited cells, the gene has to be expressed in the cells in 
which the editing is performed. 
c. As every target behaves differently depending on the specific gene and cell line one might have 
to adjust various parameters. 
 
A. Design of sgRNAs and donor plasmids 
sgRNA Design 
Identify a target site within the first intron of your target gene and generate a suitable expression 
plasmid (hereafter called pCas9/sgRNA) 
1. Most CRISPR/Cas9 expression plasmids use a CMV promoter for the expression of the Cas9 
endonuclease. In our hands, this promoter resulted in low Cas9 expression levels in human 
stem cells. While, this still resulted in successful generation of CRISPR-trap knockouts (Reber 
et al., 2018) replacement of the CMV promoter with an EF1α promoter could be considered, for 
specific cell lines in which the CMV promoter displays low activity. 
2. For the intronic sgRNA target site: 
a. Make sure to leave a spacer from the 3’ end of the first exon not to disrupt intronic splicing 
enhancers, which are typically located within the first 100 nucleotides downstream of the 5’ 
splice site (Aznarez et al., 2008). 
b. Introduce the cassette upstream of the intronic branch point to ensure proper splicing to the 
                 
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.  5 
www.bio-protocol.org/e3052     
Vol 8, Iss 20, Oct 20, 2018 
DOI:10.21769/BioProtoc.3052 
 
first exon of the target gene. Branch points are typically located < 50 nucleotides upstream 
of the 3’ splice site, with 90% of all human branch points located 37 nucleotides upstream 
of the 3’ splice site (Mercer et al., 2015). However, in certain human genes, the branch point 
can be located further upstream. Hence, we recommend the use of a splice site predictor 
such as the Human Splicing Finder available at http://www.umd.be/HSF3/ to identify the 
ideal target region. 
3. If possible, find two or more adjacent sgRNA sequences that can trigger HDR with the same 
donor plasmid, thereby enhancing the success rate. 
a. Option 1: For many genes, pre-designed and validated sgRNAs in suitable expression 
plasmids as well as custom sgRNA design are commercially available (e.g., CRISPR/Cas 
Nuclease RNA-guided Genome Editing from Sigma-Aldrich available at 
https://www.sigmaaldrich.com/technical-documents/articles/biology/crispr-cas9-genome-
editing.html#purified or from Addgene available at https://www.addgene.org/crispr/) 
b. Option 2: Use a dedicated online-tool (we typically used the CRISPR Design Tool by the 
Feng Zhang group available at http://crispr.mit.edu/) to identify CRISPR/Cas9 target 
sequences within the first intron of the gene of interest. Subsequently, clone the guide 
sequence into a suitable CRISPR/Cas9 expression plasmid (e.g., pX330-U6-Chimeric_BB-
CBh-hSpCas9, Addgene Plasmid #42230). Follow the Zhang Lab General Cloning protocol 
available at https://www.addgene.org/crispr/zhang/. 
 
Donor plasmid design 
Generate donor plasmid containing the customizable cassette either by cloning or by gene synthesis 
into a plasmid of choice. This donor plasmid is subsequently called pHDR-Don. The donor plasmids 
used in (Reber et al., 2018) for knockouts and gene replacements (pHDR-FUS KO-Zeo: generation 
of FUS knockouts & pHDR-TDP43 repl-Puro: gene replacement of TDP-43 with DD-TDP43) are 
available as Genbank files. Furthermore, pHDR-Don example constructs for gene knockouts are 
provided for genes with and without coding sequence in the first exon: pHDR-Zeo-Don for genes 
with a non-coding first exon, pHDR-Zeo-Don_f1 for genes where the splice site after the first exon 
is located directly after a codon, pHDR-Zeo-Don_f2 for genes where the splice site is located after 
1 extra nucleotide following the last codon, and pHDR-Zeo-Don_f3 for genes where the splice site 
is located after 2 extra nucleotides following the last codon. Furthermore, an example construct for 
gene replacement with a non-coding first exon is provided (pHDR-IRES-Puro-Don). 
1. We used Zeocin and puromycin as selection markers, however, depending on the targeted cell 
line alternative resistance markers such as blasticidin could be beneficial. 
In case that the endogenous gene contains some coding sequence in its first exon, make sure 
that the resistance marker/gene replacement will be spliced in-frame. 
2. Cas9 cuts 3 nucleotides upstream of the PAM motif. Homology arms 5’ and 3’ of the 
customizable cassette should therefore be identical to the sequences upstream (5’) and 
downstream (3’) of the Cas9 cleavage site. To allow efficient homology-directed repair mediated 
                 
Copyright © 2018 The Authors; exclusive licensee Bio-protocol LLC.  6 
www.bio-protocol.org/e3052     
Vol 8, Iss 20, Oct 20, 2018 
DOI:10.21769/BioProtoc.3052 
 
by pHDR-Don, we typically use homology arms with a length of 700-800 nucleotides (per 
homology arm) (see Figure 2). 
 
 
Figure 2. Schematic of the pHDR-Don design. Cas9 cuts 3 nucleotide positions upstream of 
the PAM motif. The homology arms should be identical to the sequences upstream (5’ homology) 
and downstream (3’ homology) of the cleavage site. Each homology arm should be 
approximately 750 base pairs long to ensure efficient HDR. In case of short introns, the 750 
base pairs of the 5’ homology might contain the first exon and parts of the promoter region of 
the gene of interest. In that case, make sure not to include promotor sequences in your 5’ 
homology arm to prevent expression of the cassette directly from the plasmid. 
 
3. The upstream (5’) homology arm has to be shortened, if it would contain the promoter sequence 
of the targeted gene. Otherwise, the cassette will be expressed directly from the pHDR-Don 
plasmid. 
 
B. Transfect cells 
1. Grow cells in conditions suitable for the respective cell line (growth medium, growth surface, 
growth conditions). These conditions can be maintained during the whole protocol. Seed cells 
the day before transfection in all wells of a 6-well plate. In order to seed the cells follow these 
steps: 
a. Aspirate medium from the plate containing the cells. 
b. Wash the cells once by adding a sufficient amount of PBS to cover the surface of the plate 
by gently swirling. Subsequently aspirate the PBS. 
c. Add the appropriate reagent to detach the cells (e.g., Trypsin, Accutase) and wait until the 
cells detach. 
d. Resuspend the cells in appropriate medium and count the cells (e.g., by using a 
hemocytometer). 
e. Transfer the desired amount of cells into the wells. The optimal amount of cells per well will 
vary by the cell line and the transfection reagent used. Follow the transfection reagent 
manufacturer’s protocol for an optimal transfection efficiency using a brightfield microscope 
to estimate density. 
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2. Use the appropriate transfection reagent for your cell line. In our hands, the most efficient 
transfection reagents were DogTor for HeLa cells, Mirus TransIT®-LT1 for HT1080, and human 
induced pluripotent stem cells (hiPSCs) and LipofectamineTM 3000 for SH-SY5Y neuroblastoma 
cells. Transfect each well with pCas9/sgRNA and pHDR-Don. Table 1 gives empirical values for 
successful edited cell lines in our hands (values each for the transfection of one well of a 6-well 
plate). 
 
Table 1. Empirical values for amounts of transfected plasmids. Empirical values for 
transfected pCas9/sgRNA and pHDR-Don plasmids in successful editings of various cell lines. 
Cell line pCas9/sgRNA pHDR-Don 
HeLa 2 μg 1 μg 
HT1080 1.5 μg 1.5 μg 
hiPCs 2.5 μg (+ 2.5 μg the following day) 5.5 μg (+ 5.5 μg the following day) 
SH-SY5Y 1.3 μg (+ 0.8 μg the following day) 2.7 μg (+ 6.2 μg the following day) 
 
Note: When sgRNAs for two adjacent targets were cloned, transfect 3 wells with one sgRNA 
and the other 3 wells with the other sgRNA. The 6-wells can also be used to vary either the total 
amount of transfected plasmids or the ratio between pCas9/sgRNA and pHDR-Don. A good 
starting point is to try molarity ratios of pCas9/sgRNA:pHDR-Don of 1:6 to 2:1. If 6-wells are not 
sufficient for all variation, more wells can be transfected. Since CRISPR-Trap relies on 
homology-directed repair, small molecules increasing the likelihood of these events such as 
L755507 (Yu et al., 2015; Li et al., 2017) can be added at this stage. 
3. Two to four days after transfection, detach cells using the appropriate cell detachment solution 
and pool the cells from all wells in one 15 cm dish. Let cells attach, and then start with selection 
using the selection marker introduced with the cassette. Table 2 gives empirical values for 
successful edited cell lines in our hands. 
 
Table 2. Empirical values for antibiotic selection. Empirical values for antibiotic 
concentrations and duration of selection in successful editings of various cell lines. 
Cell line Antibiotic concentration Duration 
HeLa 150 μg/ml Zeocin Until picking of the clones 
HT1080 500 μg/ml Zeocin Until picking of the clones 
hiPSCs 25 μg/ml Zeocin 3 d 
hiPSCs 0.5 μg/ml puromycin 2 d 
SH-SY5Y 250 μg/ml Zeocin Until picking of the clones 
 
C. Pick selected clones 
It is best to pick colonies while looking through a microscope, as this gives better control and reduces 
the risk of mixing multiple colonies. Here, we describe a method that allows manual picking of single 
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colonies when picking under a microscope under sterile conditions is not possible. If a microscope 
for manual picking under sterile conditions is not available, follow this protocol. Otherwise, pick 
colonies directly under the microscope under sterile conditions and continue from Step C10. 
1. Upon finishing the selection process, allow single cells to grow into colonies. It is important 
however to not let the colonies grow into to close proximity of one another, to ensure that each 
colony picked grew from one single cell. If the colonies grow to close to each other, split the 
cells to a new plate (use a cell strainer to ensure new colonies emerge from single cells). 
Note: As rule of thumb, pick colonies consisting of at least 10 cells and 1 cm of space from the 
edge to the edge of the next colonies. 
2. Count and note the number of colonies which are good to pick (i.e., consisting of at least 10 
cells and 1 cm of space from the edge to the edge of the next colonies). Use a pen to mark all 
colonies which are good to pick by circling them on the underside of the 15 cm plate (see Figure 
3). 
Note: If two colonies are too close to each other, forego to pick them to avoid picking of mixed 
colonies. 
3. Apply vacuum grease on a fresh sterile dish and use a sterile cell scraper to generate a grease 
film of approximately 5 mm thickness (Figures 3A and 3B). 
4. Prepare cloning cylinders in the number assessed in Step C2. Put cloning cylinders with their 
narrow side onto the grease. Try to avoid any horizontal movement of the cloning cylinders once 
they are sticking to the grease (Figure 3C). 
5. Sterilize 20 min under UV light. 
6. Aspirate medium from the 15 cm plate containing cells and wash once with PBS by adding 10 
ml of PBS, distributing the PBS among the plate by gently swirling and subsequently aspirating 
the PBS. 
7. Remove cloning cylinders one by one from the grease film and put them on the colonies with 
the greased side facing the plate. If you are picking without concurrent usage of a microscope, 
use the marks from Step C2 as a guide to where to put the cloning cylinders (Figure 3D). 
Note: Apply a little pressure for a watertight sealing. 
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Figure 3. Preparation of vacuum grease and cloning cylinders for manual clone picking. 
A. Apply grease on sterile dish. B. Generate an approximately 5 mm thick grease film using a 
sterile cell scraper. C. Put cloning cylinders with their narrow side onto the grease. D. Put the 
cloning cylinders with the greased side first onto the colonies. 
 
8. Add 20 μl of the appropriate reagent to detach the cells (e.g., Trypsin, Accutase) into each 
cloning cylinder and wait until the cells detach 
9. As soon as the cells detach, add 80 μl of appropriate medium into each cloning cylinder and 
directly transfer all liquid into a separate well of a 24-well plate for each colony. Subsequently 
top up medium in each well to 500 μl. 
10. Let the colonies grow over the next couple of days in the 24-well plate and transfer the cells into 
a well of a 6-well plate as soon as they reach confluence. 
Note: It is also possible to harvest clones directly from 24-wells following the same protocol from 
Procedure D. 
 
D. Validation of successful edited clones 
1. As soon as the clones reach confluence on the 6-well plates (or 24-well plates), detach the cells 
and split them into two parts. Freeze half the cells to continue with in case of a successful 
genome editing, while extracting the DNA and RNA from the other half to assess the genotype. 
Hereto we re-suspend the cells in TRIZOL to isolate gDNA as well as RNA. 
Note: A DNA extraction kit can be used as an alternative to the extraction using TRIZOL. The 
advantage of the TRIZOL extraction, however, is the possibility to simultaneously extract RNA. 
Using RT-qPCR allows for a quick check if any RNA from the target gene downstream from the 
introduced gene trap is expressed. Low traces of such RNA can indicate a mixed population of 
cells (picked clone originates not from a single cell). 
Furthermore, samples in TRIZOL can be stored for long-term at -20 °C allowing batch analysis 
of a high number of clones simultaneously. 
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2. Isolation of gDNA from TRIZOL (protocol modified from the manufacturer's protocol) 
a. Add 0.5 ml TRIZOL per well (6-well or 24-well) and pipette up and down in order to lyse the 
cells. 
b. Transfer the cell lysate into a 1.5 ml Eppendorf tube. 
c. Add 0.1 ml chloroform, close the lid tightly and shake vigorously for 15 sec. 
d. Incubate for 2-15 min at RT. 
e. Centrifuge for 15 min at 12,000 x g at 2-8 °C. 
f. Remove upper phase (contains RNA, store at -20 °C). 
g. Add 0.3 ml 100% EtOH and 1.5 μl glycogen, mix by inversion. 
Note: Adding the glycogen is essential if you work with a low amount of cells–without it, you 
won’t see a pellet in the later steps. 
h. Incubate for 2-3 min at RT. 
i. Centrifuge for 5 min at 2,000 x g at 2-8 °C. 
j. Remove supernatant. 
k. Wash DNA solution twice: 
i. Add 1 ml 0.1 M trisodium citrate, 10% EtOH. 
ii. Incubate (with occasional mixing, inversion) for at least 30 min at RT. 
iii. Centrifuge for 5 min at 2,000 x g at 2-8 °C. 
iv. Remove supernatant. 
Note: The DNA pellet is typically not attaching strongly to the tube, be careful not to 
aspirate it along with the supernatant; better leave a small amount of supernatant. 
l. Resuspend pellet in 1 ml 75% EtOH. 
m. Incubate for 10-20 min at RT. 
n. Centrifuge for 5 min at 2,000 x g at 2-8 °C. 
o. Air-dry pellet by opening the lid of the Eppendorf and placing it with the opening facing down 
on a clean tissue at room temperature for 15 min. 
p. Dissolve the pellet in 50-100 μl 8 mM NaOH with repeated pipetting. 
q. Use a Spectrophotometer (e.g., NanoDrop) to assess DNA concentration. 
Note: DNA isolated from a low amount of cells following this protocol usually results in a 
high ethanol/phenol peak measuring DNA concentration using a Spectrophotometer (e.g., 
NanoDrop). These contaminants however did not interfere with downstream PCR reactions 
in our hands (using Maximo Taq DNA Polymerase 2x-preMix [S113, GeneON] or KAPA Taq 
ReadyMix [KK1006, KAPA Biosystems]). 
r. Store at -20 °C. 
3. Isolation of RNA from TRIZOL (Protocol modified from the manufacturer's protocol) 
a. Continue with upper phase from Step D2f from DNA isolation. 
b. Add 600 μl isopropanol + 1.5 μl glycogen, invert to mix multiple times. 
c. Spin for 30 min 16,000 x g 4 °C. 
d. Wash pellet twice in 70% EtOH. 
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i. Vortex. 
ii. 15 min at 7,500 x g, 4 °C. 
iii. Remove supernatant. 
e. Air-dry pellet by opening the lid of the Eppendorf and placing it with the opening facing down 
on a clean tissue at room temperature for 10 min. 
f. Resuspend in 100 μl RNase free water. 
g. Use a Spectrophotometer (e.g., NanoDrop) to assess RNA concentration. 
h. Store at -80 °C. 
4. Use PCR to amplify the purified DNA. Use PCR product for Sanger sequencing 
Note: If possible, use primers annealing outside the homology arms of the donor plasmid to 
avoid amplifying possible traces of pHDR-Don plasmids. 
5. If the reads are ambiguous/not clean (e.g., overlap of multiple signals in the sequencing 
chromatogram after a certain point in the sequence), use TOPO-TA cloning to assess if you 
have a heterozygous clone or a mixed population. In case of a heterozygous clone, the TOPO-
TA cloning will yield E.coli colonies containing the allelic sequences in a 1:1 ratio. 
 
Notes 
 
Homozygous clones should then finally be analyzed by Western Blotting to demonstrate the 
absence of the targeted endogenous protein. An example for cell harvesting, extract preparation 
and immunoblotting is described in the original CRISPR-trap publication (Reber et al., 2018). In our 
hands, CRISPR-trap yielded no homozygous clones when targeting essential genes (lethal 
knockout). In this case, a gene replacement with a degron-tagged cDNA (see pHDR-TDP43 repl-
Puro as example) should be considered to allow an inducible depletion of the protein of interest. 
  The success rate of CRISPR-trap will depend on cell line and target gene. It is therefore difficult 
to predict the number of clones that need to be sequenced before a homozygous clone is detected. 
In our hands, the success rate for homozygous clones ranged from 10 % to 90 % of the analyzed 
clones. 
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